Related references
Note: Only part of the references are listed.Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment
Marika Premoli et al.
LIFE SCIENCES (2019)
A systematic review of cannabidiol dosing in clinical populations
S. A. Millar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers
Jacob Atsmon et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
Khalid A. Jadoon et al.
JCI INSIGHT (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Phytocannabinoids: a unified critical inventory
Lumir Ondrej Hanus et al.
NATURAL PRODUCT REPORTS (2016)
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
Istvan Ujvary et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
Fabio Arturo Iannotti et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
Peer W. F. Karmaus et al.
JOURNAL OF IMMUNOTOXICOLOGY (2013)
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
Colin Stott et al.
SPRINGERPLUS (2013)
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
Antonio Waldo Zuardi et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
R. Martin-Santos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120
Weimin Chen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
Charlotte Klein et al.
PSYCHOPHARMACOLOGY (2011)
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes
Satoshi Yamaori et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Phytocannabinoids in Cannabis sativa: Recent studies on Biosynthetic enzymes
Futoshi Taura et al.
CHEMISTRY & BIODIVERSITY (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
Erica J. Carrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
L Weiss et al.
AUTOIMMUNITY (2006)
Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract
T Nadulski et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2005)
Share Paper
